Anaptysbio (ANAB) Cash & Equivalents (2016 - 2026)
Anaptysbio's Cash & Equivalents came in at $248.47 million for Q1 2026, up 151.9% from $98.64 million a year earlier and up 4.3% from the prior quarter.
Powered by 
Analysis
Anaptysbio (ANAB) Cash & Equivalents (2016 - 2026) Analysis & Trends
At the end of FY2025, Anaptysbio's Cash & Equivalents was $238.2 million, up 93.5% from FY2024.
- Cash & Equivalents carries a five-year compound annual growth rate of -1.0% (FY2020 to FY2025).
- Going back by year, Cash & Equivalents was $123.08 million in FY2024 (+242.2%), $35.97 million in FY2023 (-49.6%), $71.31 million in FY2022 (-85.6%) and $495.73 million in FY2021 (+97.9%).
- The Q1 2026 figure represents the highest quarterly Cash & Equivalents since Q4 2021.
- Year-over-year, Cash & Equivalents increased in six of the last eight quarters, with growth averaging 152.9%.
- The fastest year-over-year change in Cash & Equivalents over five years came in Q3 2024 (growth of 628.6%), and the weakest in Q4 2022 (a decline of 85.6%).
- Business Quant data shows ANAB's Cash & Equivalents at $238.2 million (Q4 2025), $109.83 million (Q3 2025) and $44.3 million (Q2 2025) in the three quarters before Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Anaptysbio | 1.41 Bn | 296.12 Mn | - | 248.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 248.47 Mn |
| Dec 31, 2025 | 238.20 Mn |
| Sep 30, 2025 | 109.83 Mn |
| Jun 30, 2025 | 44.30 Mn |
| Mar 31, 2025 | 98.64 Mn |
| Dec 31, 2024 | 123.08 Mn |
| Sep 30, 2024 | 191.58 Mn |
| Jun 30, 2024 | 71.82 Mn |
| Mar 31, 2024 | 53.70 Mn |
| Dec 31, 2023 | 35.97 Mn |
| Sep 30, 2023 | 26.30 Mn |
| Jun 30, 2023 | 35.21 Mn |
| Mar 31, 2023 | 94.56 Mn |
| Dec 31, 2022 | 71.31 Mn |
| Sep 30, 2022 | 58.55 Mn |
| Jun 30, 2022 | 71.70 Mn |
| Mar 31, 2022 | 166.41 Mn |
| Dec 31, 2021 | 495.73 Mn |
| Sep 30, 2021 | 336.33 Mn |
| Jun 30, 2021 | 332.25 Mn |
API Access
Anaptysbio Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ANAB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "ANAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ANAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();